Saskatchewan people who need support to address problematic alcohol use now have access to another form of treatment.
As of July 1, The Saskatchewan Prescription Drug Plan will provide coverage for two drug products for the treatment of alcohol use disorder: Revia (naltrexone) and Campral (acamprosate).
“Our government is committed to providing services to help people struggling with addictions,” Health Minister Jim Reiter said. “These products are an important addition to the continuum of alcohol treatment services offered throughout Saskatchewan.”
Both drugs are used as part of an alcohol counselling program. Naltrexone is used to take away the cravings for alcohol. Acamprosate is used to maintain abstinence from alcohol in clients who have already stopped drinking.
In 2015-16, there were more than 30,000 admissions to addictions services.
The Saskatchewan formulary currently lists more than 5,400 drug products as benefits under the Drug Plan.